EMCURE:NSE
Emcure Pharmaceuticals Ltd
2 348,90 INR
arrow_downward
-0,54%(-12,80) 1D
16-ноя., 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
2 350,00 INR
High
2 389,80 INR
Low
2 326,60 INR
Mkt. cap
445,11 млд
Avg. vol.
228,06 миң
Volume
104,51 миң
Dividend
0,15%
Quarterly dividend
0,90 INR
Ex-dividend date
2026-ж., 4-сен.
P/E ratio
49,31
52-wk high
2 429,90 INR
52-wk low
1 312,30 INR
EPS
47,64 INR
No. of employees
7 миң
Open
2 350,00 INR
High
2 389,80 INR
Low
2 326,60 INR
Mkt. cap
445,11 млд
Avg. vol.
228,06 миң
Volume
104,51 миң
Dividend
0,15%
Quarterly dividend
0,90 INR
Ex-dividend date
2026-ж., 4-сен.
P/E ratio
49,31
52-wk high
2 429,90 INR
52-wk low
1 312,30 INR
EPS
47,64 INR
No. of employees
7 миң
News stories
From web sources and news partners
marketscreener.com
·
15 мүнөт мурун
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
Stocktwits
·
15 мүнөт мурун
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Benzinga
·
56 мүнөт мурун
Forget Nvidia — S&P 500's 8,900 Target Puts These ETFs in Play - State Street SPDR S&P 500 ETF Trust (ARC
BigGo Finance
·
3 саат мурун
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6,91 миң
Founded1981-ж., 16-апр.
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteemcure.com